HUP0203194A2 - Új fenil-piperazinok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk - Google Patents
Új fenil-piperazinok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásukInfo
- Publication number
- HUP0203194A2 HUP0203194A2 HU0203194A HUP0203194A HUP0203194A2 HU P0203194 A2 HUP0203194 A2 HU P0203194A2 HU 0203194 A HU0203194 A HU 0203194A HU P0203194 A HUP0203194 A HU P0203194A HU P0203194 A2 HUP0203194 A2 HU P0203194A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- general formula
- carbon
- atom
- nitrogen
- Prior art date
Links
- YZTJYBJCZXZGCT-UHFFFAOYSA-N phenylpiperazine Chemical class C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 9
- 229910052799 carbon Inorganic materials 0.000 abstract 8
- 229910052757 nitrogen Inorganic materials 0.000 abstract 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 3
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- 239000001301 oxygen Substances 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 125000004043 oxo group Chemical group O=* 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 125000004434 sulfur atom Chemical group 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 abstract 1
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 abstract 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical group C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 abstract 1
- 125000006519 CCH3 Chemical group 0.000 abstract 1
- 102000004980 Dopamine D2 Receptors Human genes 0.000 abstract 1
- 108090001111 Dopamine D2 Receptors Proteins 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 150000001721 carbon Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000000697 serotonin reuptake Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
A találmány az (I) általános képletű - ahol X jelentése (1) általánosképletű csoport, melyen belül S1 jelentése hidrogén- vagy halogénatom,S2 és S3 jelentése egymástól függetlenül hidrogénatom, 1-6 szénatomosalkil-, fenil- vagy benzilcsoport, S4 jelentése két hidrogénatom vagyegy oxocsoport, S5 jelentése hidrogénatom vagy 1-4 szénatomosalkilcsoport, Y jelentése szén-, oxigén- vagy kénatom, vagy Xjelentése (2) általános képletű csoport, melyen belül S1 jelentése afentiekben meghatározott, R jelentése hidrogénatom, 1-4 szénatomosalkil-, 2-6 szénatomos alkoxi-alkil-, 2-4 szénatomos alkenil- vagy 2-4szénatomos alkinilcsoport, vagy (3) általános képletű csoport, melyenbelül S, jelentése a fentiekben meghatározott, Z jelentése szén-,oxigén- vagy nitrogénatom, vagy (4) általános képletű csoport, melyenbelül S1 jelentése a fentiekben meghatározott, vagy (5) általánosképletű csoport, melyen belül S1 jelentése a fentiekben meghatározott,A jelentése oxigén- vagy nitrogénatom, és a csoport az 5-ös vagy 8-ashelyen kapcsolódik a piperazingyűrűhöz, vagy (6) általános képletűcsoport, melyen belül S1 jelentése a fentiekben maghatározott, S6 ésS, jelentése hidrogénatom, vagy együtt egy oxocsoportot képeznek, vagy(7) általános képletű csoport, melyen belül a szaggatott vonalakegyikének jelentése kettős kötés, S1 jelentése a fentiekbenmeghatározott, és P, T, Q jelentése nitrogénatom, vagy P és Tjelentése nitrogénatom, és Q jelentése szénatom, vagy P és Q jelentésenitrogénatom, és T jelentése szénatom vagy C-CH3 képletű csoport, vagyP jelentése nitrogénatom, T és Q jelentése szénatom, vagy P jelentésenitrogénatom, T jelentése szénatom, és Q jelentése kénatom; mjelentése 2-6; n jelentése 0-2; R5 és R6 jelentése egymástólfüggetlenül hidrogénatom, 1-3 szénatomos alkilcsoport, vagy R5 és R6együtt egy -(CH2)p- általános képletű csoportot képez, melyen belül pjelentése 3-5; és R7 jelentése 1-3 szénatomos alkil-,1-3 szénatomosalkoxicsoport, halogénatom vagy cianocsoport, vagy R6 és R7 (R7 azindolgyűrü 7-es helyén) együtt egy -(CH2)q- általános képletűcsoportot képez, melyen belül q jelentése 2-4 - új fenil-piperazin-származékokkal, ezek sóival foglalkozik, mely említett vegyületek erősaffinitást mutatnak a dopamin D2-receptorokat illetően, és jóinhibitorai a szerotonin újrafelvételnek (SRI-k). A találmány kiterjed a vegyületeket tartalmazógyógyszerkészítményekre és ezek alkalmazására központi idegrendszeribetegségek kezelésében. Ó
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL1012888 | 1999-08-23 | ||
| EP99202710 | 1999-08-23 | ||
| PCT/EP2000/008190 WO2001014330A2 (en) | 1999-08-23 | 2000-08-22 | Phenylpiperazines as serotonin reuptake inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0203194A2 true HUP0203194A2 (hu) | 2003-01-28 |
| HUP0203194A3 HUP0203194A3 (en) | 2004-01-28 |
Family
ID=26153354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0203194A HUP0203194A3 (en) | 1999-08-23 | 2000-08-22 | Phenylpiperazines, pharmaceutical compositions containing them and their use |
Country Status (30)
| Country | Link |
|---|---|
| US (3) | US7067513B1 (hu) |
| EP (1) | EP1212320B1 (hu) |
| JP (1) | JP4919565B2 (hu) |
| KR (1) | KR100634039B1 (hu) |
| CN (1) | CN1155596C (hu) |
| AR (1) | AR031526A1 (hu) |
| AT (1) | ATE299142T1 (hu) |
| AU (1) | AU772189B2 (hu) |
| BR (1) | BR0013498A (hu) |
| CA (1) | CA2379021C (hu) |
| CZ (1) | CZ298533B6 (hu) |
| DE (1) | DE60021194T2 (hu) |
| DK (1) | DK1212320T3 (hu) |
| ES (1) | ES2244469T3 (hu) |
| HK (1) | HK1051199A1 (hu) |
| HU (1) | HUP0203194A3 (hu) |
| IL (2) | IL148218A0 (hu) |
| MX (1) | MXPA02001919A (hu) |
| NO (1) | NO321887B1 (hu) |
| NZ (1) | NZ517900A (hu) |
| PL (1) | PL201178B1 (hu) |
| PT (1) | PT1212320E (hu) |
| RU (1) | RU2246494C2 (hu) |
| SI (1) | SI1212320T1 (hu) |
| SK (1) | SK287018B6 (hu) |
| TR (1) | TR200200460T2 (hu) |
| TW (1) | TWI286136B (hu) |
| UA (1) | UA74160C2 (hu) |
| WO (1) | WO2001014330A2 (hu) |
| ZA (1) | ZA200201829B (hu) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4919565B2 (ja) | 1999-08-23 | 2012-04-18 | アボツト・ヘルスケア・プロダクツ・ベー・ブイ | 新規なフェニルピペラジン |
| AR032712A1 (es) * | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen |
| AR032711A1 (es) | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | Derivados de fenilpiperazina, un metodo para la preparacion de los mismos y una composicion farmaceutica que los contiene |
| EP1381600A1 (en) | 2001-04-24 | 2004-01-21 | Wyeth, A Corporation of the State of Delaware | Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan |
| US7041683B2 (en) | 2001-04-24 | 2006-05-09 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1, 4-benzodiozan |
| US6656950B2 (en) | 2001-04-25 | 2003-12-02 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine |
| EP1336406A1 (en) * | 2002-02-14 | 2003-08-20 | Solvay Pharmaceuticals B.V. | Partial dopamine-D2 receptor agonist plus serotonin and/or noradrenaline inhibitory activity |
| MXPA04011254A (es) * | 2002-05-13 | 2005-01-25 | Hoffmann La Roche | Derivados de benzoxazina como moduladores de 5-hidroxitriptamina 6 (5-ht6) y usos de los mismos. |
| DE10233500A1 (de) * | 2002-07-24 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel |
| DK1562918T3 (da) * | 2002-11-08 | 2008-05-05 | Hoffmann La Roche | Substituerede benzoxazinoner og anvendelser deraf |
| US7276603B2 (en) | 2003-05-02 | 2007-10-02 | Wyeth | Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use |
| WO2004108671A1 (en) * | 2003-06-06 | 2004-12-16 | Suven Life Sciences Limited | Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them |
| CA2587928A1 (en) * | 2004-12-07 | 2006-06-15 | Solvay Pharmaceuticals B.V. | Phenylpiperazines with a combination of affinity for dopamine -d2 receptors and serotonin reuptake sites |
| TW200631952A (en) * | 2004-12-07 | 2006-09-16 | Solvay Pharm Bv | Benzdioxan piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites |
| US7371769B2 (en) | 2004-12-07 | 2008-05-13 | Solvay Pharmaceuticals B.V. | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites |
| US20070072870A2 (en) | 2004-12-08 | 2007-03-29 | Solvay Pharmeceuticals B.V. | Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| RU2007125659A (ru) * | 2004-12-08 | 2009-01-20 | Солвей Фармасьютикалс Б.В. (Nl) | Фенилпиперазиновые производные с сочетанием свойств неполного агонизма к рецепторам дофамина-d2 и ингибирования повторного поглощения серотонина |
| GT200600414A (es) * | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine | |
| GT200600416A (es) | 2005-09-12 | 2007-09-20 | Sales salicilato y gentisato de un compuesto de piperazina | |
| AR055424A1 (es) | 2005-09-12 | 2007-08-22 | Wyeth Corp | Formulacion de liberacion sostenida y usos de la misma |
| US9066903B2 (en) | 2006-02-28 | 2015-06-30 | The United States Of America As Represented By The Department Of Veterans Affairs | Pharmacological treatment of Parkinson's disease |
| FR2941946B1 (fr) * | 2009-02-12 | 2011-03-25 | Sanofi Aventis | Derives de 3-benzofuranyl-indol-2-one-3-acetamidopiperazines substitues, leur preparation et leur application en therapeutique |
| US8686009B2 (en) * | 2009-06-25 | 2014-04-01 | Alkermes Pharma Ireland Limited | Prodrugs of NH-acidic compounds |
| US9598401B2 (en) | 2013-07-29 | 2017-03-21 | Sunshine Lake Pharma Co., Ltd. | Substituted heteroaryl compounds and methods of use thereof |
| WO2016192657A1 (en) | 2015-06-03 | 2016-12-08 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1075156A (en) | 1963-08-27 | 1967-07-12 | Luso Farmaco Inst | Substituted piperazines |
| GB8830312D0 (en) | 1988-12-28 | 1989-02-22 | Lundbeck & Co As H | Heterocyclic compounds |
| DE4127849A1 (de) * | 1991-08-22 | 1993-02-25 | Merck Patent Gmbh | Benzodioxanderivate |
| US5314896A (en) | 1991-11-20 | 1994-05-24 | Warner-Lambert Company | 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
| DE4333254A1 (de) * | 1993-09-30 | 1995-04-06 | Merck Patent Gmbh | Piperidine und Piperazine |
| DE4414113A1 (de) | 1994-04-22 | 1995-10-26 | Merck Patent Gmbh | 3-Indolylpiperidine |
| US5576321A (en) | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| AR004229A1 (es) | 1995-11-06 | 1998-11-04 | Wyeth Corp | Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos |
| ZA9711376B (en) | 1996-12-20 | 1998-07-21 | Lundbeck & Co As H | Indole or dihydroindole derivatives |
| DE19730989A1 (de) | 1997-07-18 | 1999-01-21 | Merck Patent Gmbh | Piperazin-Derivate |
| WO1999005140A1 (en) * | 1997-07-25 | 1999-02-04 | H. Lundbeck A/S | Indole and 2,3-dihydroindole derivatives, their preparation and use |
| ATE253058T1 (de) * | 1997-09-02 | 2003-11-15 | Duphar Int Res | Piperidin- und piperazin derivate als 5-ht1- rezeptor-agonisten |
| EP0900792B1 (en) | 1997-09-02 | 2003-10-29 | Duphar International Research B.V | Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists |
| KR20010071513A (ko) * | 1998-06-19 | 2001-07-28 | 피터슨 존 메이달 | 4,5,6 및 7-인돌 및 인돌린 유도체, 그것들의 제조 및 용도 |
| CA2335711A1 (en) | 1998-06-19 | 1999-12-29 | Ivan Mikkelsen | 4,5,6 and 7-indole and indoline derivatives, their preparation and use |
| AR020773A1 (es) | 1998-10-16 | 2002-05-29 | Duphar Int Res | Compuesto derivados de 3-(tetrahidropiridin-4-il)indol, metodo para prepararlo, una composicion farmaceutica que los contiene, metodo para preparar dicha composicion y uso del compuesto |
| AR022303A1 (es) * | 1999-01-22 | 2002-09-04 | Lundbeck & Co As H | Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion |
| JP4919565B2 (ja) | 1999-08-23 | 2012-04-18 | アボツト・ヘルスケア・プロダクツ・ベー・ブイ | 新規なフェニルピペラジン |
| AR032711A1 (es) | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | Derivados de fenilpiperazina, un metodo para la preparacion de los mismos y una composicion farmaceutica que los contiene |
| AR032712A1 (es) * | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen |
| EP1336406A1 (en) | 2002-02-14 | 2003-08-20 | Solvay Pharmaceuticals B.V. | Partial dopamine-D2 receptor agonist plus serotonin and/or noradrenaline inhibitory activity |
-
2000
- 2000-08-22 JP JP2001518420A patent/JP4919565B2/ja not_active Expired - Fee Related
- 2000-08-22 DK DK00962355T patent/DK1212320T3/da active
- 2000-08-22 UA UA2002032313A patent/UA74160C2/uk unknown
- 2000-08-22 AT AT00962355T patent/ATE299142T1/de active
- 2000-08-22 AR ARP000104326A patent/AR031526A1/es active IP Right Grant
- 2000-08-22 AU AU74118/00A patent/AU772189B2/en not_active Ceased
- 2000-08-22 IL IL14821800A patent/IL148218A0/xx active IP Right Grant
- 2000-08-22 TR TR2002/00460T patent/TR200200460T2/xx unknown
- 2000-08-22 SI SI200030720T patent/SI1212320T1/xx unknown
- 2000-08-22 CZ CZ20020619A patent/CZ298533B6/cs not_active IP Right Cessation
- 2000-08-22 NZ NZ517900A patent/NZ517900A/en not_active IP Right Cessation
- 2000-08-22 PL PL364821A patent/PL201178B1/pl not_active IP Right Cessation
- 2000-08-22 DE DE60021194T patent/DE60021194T2/de not_active Expired - Lifetime
- 2000-08-22 PT PT00962355T patent/PT1212320E/pt unknown
- 2000-08-22 BR BR0013498-8A patent/BR0013498A/pt active Search and Examination
- 2000-08-22 SK SK249-2002A patent/SK287018B6/sk not_active IP Right Cessation
- 2000-08-22 MX MXPA02001919A patent/MXPA02001919A/es active IP Right Grant
- 2000-08-22 CN CNB008118655A patent/CN1155596C/zh not_active Expired - Fee Related
- 2000-08-22 ES ES00962355T patent/ES2244469T3/es not_active Expired - Lifetime
- 2000-08-22 EP EP00962355A patent/EP1212320B1/en not_active Expired - Lifetime
- 2000-08-22 KR KR1020027002242A patent/KR100634039B1/ko not_active IP Right Cessation
- 2000-08-22 CA CA002379021A patent/CA2379021C/en not_active Expired - Fee Related
- 2000-08-22 WO PCT/EP2000/008190 patent/WO2001014330A2/en active IP Right Grant
- 2000-08-22 HU HU0203194A patent/HUP0203194A3/hu unknown
- 2000-08-22 US US10/069,256 patent/US7067513B1/en not_active Expired - Fee Related
- 2000-08-22 RU RU2002107318/04A patent/RU2246494C2/ru not_active IP Right Cessation
- 2000-09-01 TW TW089117890A patent/TWI286136B/zh not_active IP Right Cessation
-
2002
- 2002-02-18 IL IL148218A patent/IL148218A/en not_active IP Right Cessation
- 2002-02-19 NO NO20020810A patent/NO321887B1/no not_active IP Right Cessation
- 2002-03-05 ZA ZA200201829A patent/ZA200201829B/xx unknown
-
2003
- 2003-05-16 HK HK03103471A patent/HK1051199A1/xx not_active IP Right Cessation
-
2006
- 2006-06-12 US US11/450,323 patent/US7456182B2/en not_active Expired - Fee Related
-
2008
- 2008-10-27 US US12/258,591 patent/US7605162B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0203194A2 (hu) | Új fenil-piperazinok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| NI200600257A (es) | Nuevos compuestos. | |
| HUP9902471A2 (hu) | Piperazin- és piperidinvegyületek, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
| HUP0301745A2 (hu) | Ciklopentánindolok, ezeket tartalmazó gyógyszerkészítmények és a vegyületek alkalmazása | |
| MXPA05011710A (es) | Derivados de pirimidina con actividad de crf. | |
| HUP0300693A2 (hu) | Eljárás epotilon-analógok és -intermedierek előállítására | |
| HUP0003700A2 (hu) | Kondenzált gyűrűs szubsztituenseket tartalmazó 2-aminopiridinek mint NOS inhibitorok | |
| HUP0302167A2 (hu) | Metabotropikus glutamát receptor antagonista hatású kinolinszármazékok, a vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
| HUP0301573A2 (hu) | Szubsztituált arilpirazinok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP0402236A2 (hu) | Heterociklusos vegyületek, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| MEP25608A (en) | Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics | |
| IS7982A (is) | Ný efnasambönd | |
| MXPA03011244A (es) | Nuevos derivados de indol con afinidad por el receptor 5-ht6. | |
| ATE219071T1 (de) | Tricyclische verbindungen mit bindungsaffinität für melatoninrezeptoren, deren herstellung und verwendung | |
| DE60320012D1 (de) | Aminoheterocyclen als vr-1 antagonisten zur behandlung von schmerzen | |
| EA200600811A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ | |
| WO2006021655A3 (fr) | Dérivés doxopiperidine, leur préparation et leur application en thérapeutique | |
| HUP0203575A2 (hu) | Th2 differenciálódás inhibitorokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP0302468A2 (hu) | Alfa V integrin receptor antagonisták és ezeket tartalmazó gyógyszerkészítmények | |
| KR880012227A (ko) | 도파민 수용체 길항제의 신규사용법 | |
| HUP0003413A2 (hu) | Új kondenzált piridinszármazékok, eljárás előállításukra és az azokat tartalmazó gyógyászati készítmények | |
| HUP0301458A2 (hu) | Benzoxazinonszármazékok, eljárás előállításukra és a vegyületek felhasználása | |
| HUP0303270A2 (hu) | Antidepresszáns hatású izoxazolinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0203332A2 (hu) | Ciklotiokarbamát-származékok, progeszteron receptor modulátorokként való alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0402602A2 (hu) | Eljárás echinokandin-származékok előállítására, ezek alkalmazása, ezeket tartalmazó gyógyszerkészítmények és intermedierek |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |